Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study
Maximilian Stahl, Rory M. Shallis, Wei Wei, Pau Montesinos, Étienne Lengliné, Judith Neukirchen, Vijaya Raj Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Selina M. Luger, Irum Khan, Gail J. Roboz, Thomas Cluzeau, David Martínez‐Cuadrón, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukherjee, Andrew M. Brunner, Adam R. Miller, Christine M. McMahon, Ellen K. Ritchie, Rebeca Rodríguez‐Veiga, Raphaël Itzykson, Blanca Boluda, Florence Rabian, Mar Tormo, Evelyn Acuña‐Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A. Podoltsev, Jan Philipp Bewersdorf, Steven D. Gore, Amer M. Zeidan
Topics & Concepts
LeukapheresisMedicineLeukostasisHazard ratioProportional hazards modelInternal medicineMyeloid leukemiaSurgeryLeukemiaConfidence intervalStem cellBiologyGeneticsCD34Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processes